<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01170819</url>
  </required_header>
  <id_info>
    <org_study_id>1229</org_study_id>
    <nct_id>NCT01170819</nct_id>
  </id_info>
  <brief_title>Double Balloon Catheter Versus Dinoprostone Vaginal Insert for Cervical Ripening.</brief_title>
  <official_title>Double Balloon Catheter Versus Vaginal PGE2 for Pre-induction Cervical Ripening: a Randomized Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi dell'Insubria</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi dell'Insubria</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the efficacy of transcervical double balloon catheters versus controlled release
      dinoprostone vaginal inserts for pre-induction cervical ripening in term women with
      unfavourable cervices.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal delivery within 24 hours</measure>
    <time_frame>24 hours from start of cervical ripening</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cesarean section rate</measure>
    <time_frame>48 hours from start of ripening</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Onset of active labor</measure>
    <time_frame>36 hours from start of ripening</time_frame>
    <description>Active labor is defined as at least 4 uterine contractions in a 30 minutes interval with a totally effaced cervix and a cervical dilatation ≥3 cm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uterine hyperstimulation</measure>
    <time_frame>12 hours (double ballon catheter arm) and 24 hours (dinoprostone vaginal insert arm) from start of ripening</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">210</enrollment>
  <condition>Cervical Ripening</condition>
  <condition>Labor Induction</condition>
  <arm_group>
    <arm_group_label>Dinoprostone Vaginal Insert</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Double Balloon Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Double balloon catheter</intervention_name>
    <description>The balloons either side of the cervix are inflated with 50 ml of water. The catheter is removed after 12 hours if spontaneous expulsion has not occurred.</description>
    <arm_group_label>Double Balloon Catheter</arm_group_label>
    <other_name>COOK CERVICAL BALLOON, COOK UROLOGICAL INC. US</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dinoprostone 10 mg controlled-release vaginal insert</intervention_name>
    <description>Vaginal insert is placed in the posterior vaginal fornix for a maximum period of 24 hours.</description>
    <arm_group_label>Dinoprostone Vaginal Insert</arm_group_label>
    <other_name>PROPESS®, Ferring Pharmaceuticals</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton gestation

          -  gestational age greater than 34 weeks

          -  cephalic presentation

          -  intact membranes

          -  Bishop score of ≤4

          -  reactive fetal heart rate (FHR) pattern on admission

        Exclusion Criteria:

          -  any condition precluding vaginal delivery

          -  any contraindication to receiving prostaglandins, including history of asthma,
             glaucoma, or cardiac or cardiovascular disease

          -  previous cesarean section or other uterine incision
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Del Ponte Hospital</name>
      <address>
        <city>Varese</city>
        <zip>21100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2010</study_first_submitted>
  <study_first_submitted_qc>July 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2010</study_first_posted>
  <last_update_submitted>December 9, 2011</last_update_submitted>
  <last_update_submitted_qc>December 9, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 13, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi dell'Insubria</investigator_affiliation>
    <investigator_full_name>Antonella Cromi</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Cervical ripening</keyword>
  <keyword>Induction of labor</keyword>
  <keyword>Prostaglandins</keyword>
  <keyword>Mechanical methods</keyword>
  <keyword>Balloon catheter</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dinoprostone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

